Medicinal Products
Dail Éireann — 2024-02-29
============================================================

Aindrias Moynihan (FF), Cork North-West

I first wish to acknowledge that significant work has been done on women's health across a range of different services. That is very positive. I refer to IVF, gynaecological services, for example, in Cork, and menopause clinics. This measure would complement the great effort that has been advanced through menopause clinics. A small number of people are involved in this and they have very limited options, if any at all. This is their first opportunity to have an option available to them because it is a non-hormone-based drug. Their options are limited because of their cancer treatment, which means they will not be able to use any hormone-based drugs. Can the fact that very limited alternatives are available to these people inform the decision? Can it inform and expedite the decision to put it on the drugs payment scheme at a manageable price?

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2024-02-29/debate/main
Retrieved: 2026-08-14T04:52:44+00:00
Sitting date: 2024-02-29